BioRem Inc. has had a mixed week, with no significant news affecting its stock price.
BioRem Inc. (BRM.V) closed at C$3.02, reflecting a modest gain of 1.00% on the last trading day. However, the stock has seen a slight decline of 0.33% over the past week and a more substantial decrease of 2.88% over the last month. On a positive note, the year-to-date performance shows a growth of 14.34%. Let’s take a closer look at the recent performance and technical indicators for BioRem.
Investor takeaway: Investors should consider BioRem’s recent financial performance, particularly its record revenues and order backlog, while also paying attention to technical indicators that present a mixed picture.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
BioRem Inc.
BRM.V
BRM.V
BioRem Inc.
WealthAwesomeMarket cap
$49.03M
P/E
11.2x
52W high
$3.57
52W low
$1.87
1W change
-0.33%
Beta
0.88
Analyst Price Targets
Based on analyst covering BRM
Wall Street analysts forecast BRM stock price to rise 15.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.50
+15.5% Upside
Current Price
C$3.03
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRM's historical volatility
30-Day Vol
15.0%
Annualized
90-Day Vol
45.5%
Annualized
Trend (90d)
-35.9%
Annualized drift
90d Mean
C$2.67
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.90 | C$2.76 – C$3.06 |
| 60 trading days | C$2.78 | C$2.59 – C$2.99 |
| 90 trading days | C$2.67 | C$2.44 – C$2.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
C$3.02 Closing Price with Year-to-Date Gain of 14.34%
The stock's 52-week range of C$1.87 – C$3.57 indicates it is currently trading at 68% of its range, suggesting there is potential for growth or risk of decline.
Bull case
The company has reported record revenues and earnings before tax for 2025, highlighting strong operational performance. Additionally, a significant order backlog of $65.3 million points to future revenue potential.
Bear case
Despite the positive fundamentals, the stock has shown volatility in the short term, with recent declines in both weekly and monthly performance that may concern some investors.
Recent Performance Overview
BioRem Inc. closed at C$3.02, with a 1D increase of 1.00%. However, over the past week, the stock has decreased slightly by 0.33%, and it shows a decline of 2.88% over the last month. Year-to-date, BioRem has performed well with a gain of 14.34%. This trend highlights some volatility, particularly in the short term.
Company News and Catalysts
There were no major news announcements from BioRem this week. However, several recent headlines have focused on the company's financial performance. Notably, BioRem reported record revenues and earnings before tax for the fiscal year ending December 31, 2025, with a remarkable 60% increase in earnings over the previous year. The company also has a significant order backlog of $65.3 million, a 16% increase from the previous year, which could support future revenue growth.
Technical Picture
Looking at the technical indicators, BioRem's last close was C$3.02, which is 2.9% below the 50-day moving average of C$3.11. In contrast, it is trading 12.7% above its 200-day moving average of C$2.68. The stock's 52-week range is between C$1.87 and C$3.57, placing it at 68% of its range. With a beta of 0.88, BioRem's stock has shown lower volatility compared to the market, which could appeal to risk-averse investors. The latest trading volume of 11,405 shares is slightly below the 20-day average volume of 11,807 shares.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
